SLC6A3 and Parkinson disease: Enriched cohorts, i.e., individuals with a relatively increased risk of developing PD due to stratification by prodromal/risk factors (male gender, TCS SN+, positive dopamine transporter scintigraphy, PD relatives), may have a higher PD conversion rate, thus providing greater statistical power for a given sample size or shorter study duration.